- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech High Insider Buying
Swedish Pharmaceuticals & Biotech High Insider Buying
Results
10
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
10 companies
AddLife
Market Cap: SEK 18.1b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 148.70
7D
5.8%
1Y
45.9%
Biotage
Market Cap: SEK 7.2b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 90.40
7D
4.8%
1Y
-47.6%
Swedencare
Market Cap: SEK 5.8b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 36.05
7D
0.1%
1Y
-41.3%
MedCap
Market Cap: SEK 5.6b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 370.50
7D
9.5%
1Y
-9.9%
Devyser Diagnostics
Market Cap: SEK 1.5b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 91.20
7D
-0.8%
1Y
-12.3%
Enzymatica
Market Cap: SEK 825.3m
A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.
ENZY
SEK 3.40
7D
-4.5%
1Y
-6.1%
Mendus
Market Cap: SEK 249.0m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 4.95
7D
-8.3%
1Y
-52.6%
Biovica International
Market Cap: SEK 76.9m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.79
7D
-12.9%
1Y
-65.5%
OncoZenge
Market Cap: SEK 59.6m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 5.09
7D
18.2%
1Y
24.1%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%